LUYAN PHARMA(SZ:002788) Sou Hu Cai Jing·2026-01-18 18:11Core Viewpoint - Luyuan Pharmaceutical (002788) has experienced significant stock price declines, with a 10.01% drop on January 16, 2026, marking its second consecutive trading halt and a cumulative decline of 7.2% over the past ten trading days [1][2]. Trading Information Summary - On January 16, 2026, Luyuan Pharmaceutical closed at 19.68 yuan, with a trading volume of 51,662 shares and a total transaction value of 5.1662 million yuan [2]. - The stock has seen a net outflow of 759 million yuan from major funds over the first ten trading days, with 241.769 million yuan net outflow on January 16 alone [2]. - The stock has been on the "Dragon and Tiger List" for the second time in five trading days due to a cumulative price deviation exceeding 20% [2][6]. Company Announcement Summary - Luyuan Pharmaceutical confirmed that its stock price has deviated significantly over three consecutive trading days, but the company stated that its operational status remains normal and there are no undisclosed significant matters affecting the stock price [3][6]. - The company and its major shareholders have not engaged in any stock trading during the period of abnormal price fluctuations [3]. Latest Responses from the Secretary - The company has been asked about the status of its AI medical applications and recent important changes, to which the secretary advised investors to refer to official announcements for major information [4][5]. - The company is adjusting its operational strategies based on market feedback while adhering to regulatory requirements [5].